Skip to content

EVOLENCE® Assessment of Recovery Time and Impact of Dermal Filler Selection: The E-ART™ Study

EVOLENCE® Assessment of Recovery Time and Impact of Dermal Filler Selection: The E-ART™ Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00911872
Enrollment
30
Registered
2009-06-02
Start date
2008-01-31
Completion date
2008-08-31
Last updated
2009-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

wrinkles, dermal filler, collagen, soft tissue augmentation, aesthetic

Brief summary

The purpose of this study is to gather information about the immediate effects and recovery time for treatment with EVOLENCE/EVOLENCE BREEZE for soft tissue augmentation. The time it takes for patients to feel comfortable with the results, and return to their normal daily routine is also of important interest

Detailed description

The primary objective of this Investigator Initiated Study is to document recovery time/return to daily activities following facial soft-tissue augmentation with an EVOLENCE dermal filler. In addition, the immediate effects such as swelling, bleeding, bruising will be assessed.

Interventions

DEVICEcollagen (EVOLENCE)

injectable collagen

Sponsors

Solish, Nowell, M.D.
Lead SponsorINDIV

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or Female \> 18 years of age * Need for soft tissue augmentation as evidenced by any of the following: * Bilateral-aging defects \> 1 on the Modified Fitzpatrick Wrinkle Scale * Decrease in soft tissue volume in other areas of the face

Exclusion criteria

* History of positive hypersensitivity to porcine collagen-based products History of multiple food, drug, and substance allergies Autoimmune or collagen vascular disease Facial tissue augmentation within 6 months (HA) or 12 months Evolence/Evolence Breeze Botulinum-toxin A within 6 weeks Ablative laser treatments within 12 months Permanent facial implants Investigational product use within 30 days Pregnant and/or nursing woman or woman who plan to become pregnant during the study.

Design outcomes

Primary

MeasureTime frame
Is to document recovery time/return to daily activities following facial soft-tissue augmentation with an EVOLENCE dermal filler7 Days

Secondary

MeasureTime frame
the immediate effects such as swelling, bleeding, bruising will be assessed7 Days

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026